Status:
COMPLETED
Post-COVID-19 Patients With Trak Tool
Lead Sponsor:
Trak Health Solutions S.L.
Conditions:
Post COVID-19 Condition
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The clinical trial aims to analyse the effectiveness of a physiotherapeutic exercise program delivered through the telerehabilitation tool (Trak) compared to a booklet-based rehabilitation format in p...
Detailed Description
The study recruitment process targets individuals who have experienced COVID-19 (moderate or severe), regardless of whether they required hospital admission, and who necessitate rehabilitation post-di...
Eligibility Criteria
Inclusion
- Patients that have suffered COVID-19 \[COVID-19-moderate: clinical signs of pneumonia (fever, cough, dyspnea, tachypnea), but without signs of severe pneumonia, particularly oxygen saturation greater than or equal to 90% with air atmosphere; COVID-19-severe: clinical signs of pneumonia (fever, cough, dyspnea, tachypnea) plus one of the following: frequency respiratory \> 30 inspirations/min; severe dyspnea; treatment oral medication.\]
- Patients with COVID-19-related muscle pain.
- Patients with a personal device such as a tablet, smartphone, or laptop operate agilely with these devices.
- Patients with email.
- Signing of the informed consent.
Exclusion
- Patients with a resting heart rate higher than 110 beats per minute.
- Patients with blood pressure less than 90/60 or over 160/95.
- Patients with lower blood oxygen saturation of 90%.
- Patients with advanced cognitive impairment.
Key Trial Info
Start Date :
March 16 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 5 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06492551
Start Date
March 16 2022
End Date
October 5 2022
Last Update
July 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asunción Klinika
Tolosa, Gipuzkoa, Spain, 20400